Breast cancer is a heterogeneous disease, and the molecular subtypes of breast cancer are classified based on the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [2]. This evidence concerns the gene ERBB2 and breast cancer.